Pulsion Medical Systems SE (PUS)
Market Open
20 Nov, 07:01
XMUN XMUN Primary €
21. 60
0
0%
€
144.29M Market Cap
20.11 P/E Ratio
0.88% Div Yield
0 Volume
0 Eps
€ 21.6
Previous Close Day Range
21.6 21.6
Year Range
15.9 22
Want to track PUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
PUS trading today higher at €21.6, an increase of 0% from yesterday's close, completing a monthly increase of 1.89% or €0.4. Over the past 12 months, PUS stock gained 35.85%.
PUS is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XMUN (EUR).
Pulsion Medical Systems SE (PUS) FAQ
What is the stock price today?
The current price is €21.60.
On which exchange is it traded?
Pulsion Medical Systems SE is listed on XMUN.
What is its stock symbol?
The ticker symbol is PUS.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.88%.
What is its market cap?
As of today, the market cap is 144.29M.
Has Pulsion Medical Systems SE ever had a stock split?
No, there has never been a stock split.
Pulsion Medical Systems SE Profile
| Health Care Technology Industry | Healthcare Sector | Mr. Stephan Haft CEO | XMUN Exchange | DE0005487904 ISIN |
| DE Country | 130 Employees | 1 Jul 2025 Last Dividend | - Last Split | - IPO Date |
Overview
PULSION Medical Systems SE, established in 1990 and headquartered in Feldkirchen, Germany, specializes in the development, manufacture, and distribution of advanced monitoring, diagnosis, and therapy control systems. These systems are designed for the management of physiological parameters in hospitalized, seriously ill, and intensive care patients. The company's commitment to innovation has positioned it as a key player in offering technologies that improve patient outcomes in critical care settings.
Products and Services
- PiCCO platform: This system is a cornerstone in intensive care medicine, facilitating the treatment of critically ill patients by allowing detailed monitoring and assessment of the cardiovascular system. Its importance lies in its accuracy and reliability, which support critical decisions in patient care.
- PulsioFlex: Known for its application in perioperative medicine, this technology provides valuable insights into the patient's physiological status. It enhances the ability to monitor and adjust to the needs of patients undergoing major surgical procedures, ensuring a personalized approach to care.
- PiCCO catheter: Specifically designed for cardiovascular monitoring, the PiCCO catheter is integral to the PiCCO platform. It offers a minimally invasive method to obtain crucial data on the heart's performance and the patient's fluid balance.
- ProAQT: A sensor that has become indispensable in managing high-risk patients and interventions. ProAQT facilitates continuous monitoring, playing a vital role in the early detection of hemodynamic instability.
- CeVOX: This technology is dedicated to the continuous monitoring of a patient's oxygen balance. By ensuring real-time data on oxygen levels, CeVOX is instrumental in preventing hypoxia and managing oxygen therapy effectively.
- LiMON: LiMON technology offers a non-invasive solution to assess and monitor liver function. This is particularly beneficial in the critical care setting, where liver function can be a key indicator of patient recovery or deterioration.
- NICCI: The latest addition to PULSION's hemodynamic monitoring portfolio. NICCI provides continuous, non-invasive blood pressure monitoring, enhancing the ability to assess and respond to a patient's dynamic circulatory needs.
Contact Information
Address: Hans-Riedl-Str. 21, Feldkirchen, Germany, 85622
Phone: 49 89 459 9140
2025 © Marketlog. All Rights Reserved.
